ConductScience.org, home

Trial · NCT00247572

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

NCT00247572, Phase 2, Completed, New River Pharmaceuticals

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories. Trials, record NCT00247572. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00247572

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
NCT number
NCT00247572
Status
Completed
Phases
Phase 2
Enrollment
12 participants
Lead sponsor
New River Pharmaceuticals
Conditions
Attention Deficit Disorder With Hyperactivity, Amphetamine-Related Disorders, Substance-Related Disorders
Interventions
NRP104
First posted
2005-11-02
Last updated
2007-11-05

Source ClinicalTrials.gov

Registered outcomes19

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPharmacodynamic (PD) Parameters:
PrimaryThe following parameters will be measured at fixed time intervals post drug and used to compare the
Primaryeffects of various doses of NRP104 with placebo and d-amphetamine sulfate for pharmacodynamic
Primaryequivalence:
Primary(1) Maximum liking scale scores for euphoria measured by DRQS and DRQO
Primary(2) Maximum disliking scale scores for dysphoria measured by DRQS and DRQO
Primary(3) Maximum scores on the MBG, BG and Amphetamine scales of the ARCI
Primary(4) Maximum supine systolic and diastolic blood pressure changes from baseline
Primary(5) Maximum orthostatic pulse increases from baseline
Primary(6) Spontaneous reports of discomforting subjective effects

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00247572

GET https://conductscience.org/api/trials/v1/NCT00247572/registered